High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.
about
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and ErkMetformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib.Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway.Down-regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer.
P2860
High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
High efficacy of intravesical ...... r cancer in preclinical model.
@en
type
label
High efficacy of intravesical ...... r cancer in preclinical model.
@en
prefLabel
High efficacy of intravesical ...... r cancer in preclinical model.
@en
P2093
P2860
P356
P1433
P1476
High efficacy of intravesical ...... r cancer in preclinical model.
@en
P2093
Alex F Chen
Hongwei Lv
Qiongli Su
Xiaohui Li
P2860
P304
P356
10.18632/ONCOTARGET.6933
P407
P577
2016-01-18T00:00:00Z